Relation between C reactive protein concentrations and coronary microvascular endothelial function

Objective: To determine how C reactive protein (CRP), a sensitive marker of inflammation, is related to coronary endothelial function. Design: Changes in quantitative coronary angiographic findings and Doppler flow velocity measurements in response to locally infused acetylcholine were assessed. Setting: Tertiary cardiology centre. Patients: 46 patients with angiographically normal coronary arteries were divided into groups with normal (⩽ 3 mg/l) or increased (> 3 mg/l) CRP concentrations. Interventions: Acetylcholine (3 and 30 μg/min) was infused into the left coronary ostium for two minutes. Main outcome measures: Percentage change in diameter of epicardial coronary arteries and coronary blood flow (CBF) in response to acetylcholine; and correlations between these parameters and serum CRP concentrations. Results: 15 patients had increased CRP concentrations. The change in coronary artery diameter induced by acetylcholine infusion was similar between the groups but the increase in CBF induced by acetylcholine was smaller in patients with increased CRP concentrations (54.9% v 139.4% with acetylcholine 30 μg/min, p  =  0.0030). Multivariate analysis identified increased CRP concentration as independently associated with attenuated CBF response to acetylcholine at 30 μg/min (p  =  0.0078, R2  =  0.434). Conclusions: These findings suggest that inflammation appears to be associated with impaired coronary endothelial function in resistance but not conduit vessels. The data suggest a close relation between chronic vascular inflammation and endothelial dysfunction in atherosclerosis.

[1]  Heart Online case reports: www.heartjnl.com , 2003 .

[2]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[3]  K. Chayama,et al.  Leptin causes nitric-oxide independent coronary artery vasodilation in humans. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[4]  G. Lowe,et al.  Endothelial dysfunction and inflammation in asymptomatic proteinuria. , 2003, Kidney international.

[5]  Kathleen M. Weil,et al.  Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[7]  P. Ridker.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[8]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[9]  Ren-Ke Li,et al.  A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis , 2002, Circulation.

[10]  A. Hingorani,et al.  Prevention of Inflammation-Induced Endothelial Dysfunction: A Novel Vasculo-Protective Action of Aspirin , 2002, Circulation.

[11]  K. Chayama,et al.  Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia , 2002, Heart.

[12]  F. Crea,et al.  Unstable Angina and Elevated C-Reactive Protein Levels Predict Enhanced Vasoreactivity of the Culprit Lesion , 2001, Circulation.

[13]  P. Libby,et al.  Endothelial function and coronary artery disease , 2001, Current opinion in lipidology.

[14]  G. Kajiyama,et al.  Magnesium causes nitric oxide independent coronary artery vasodilation in humans , 2001, Heart.

[15]  Peter Libby,et al.  Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.

[16]  J. Kooner,et al.  C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites , 2001, Circulation.

[17]  N Rifai,et al.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. , 2001, JAMA.

[18]  S. Devaraj,et al.  Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. , 2001, Journal of the American College of Cardiology.

[19]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[21]  P. Mills,et al.  The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. , 2001, Journal of the American College of Cardiology.

[22]  B. Horne,et al.  Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. , 2000, Journal of the American College of Cardiology.

[23]  J. Townend,et al.  Endothelial Function : Lessons for Atherosclerotic Disease ? Suppression of Inflammation in Primary Systemic Vasculitis Restores Vascular , 2000 .

[24]  S. Fichtlscherer,et al.  Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.

[25]  J. Connell,et al.  Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. , 2000, Clinical science.

[26]  M. Nieminen,et al.  Relation of inflammation to vascular function in patients with coronary heart disease. , 2000, Atherosclerosis.

[27]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[28]  Aroon D. Hingorani,et al.  Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans , 1999, Circulation.

[29]  F. Crea,et al.  Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. , 2000, The American journal of cardiology.

[30]  P. Nihoyannopoulos,et al.  Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. , 1999, Circulation.

[31]  D. Bharadwaj,et al.  The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II , 1999 .

[32]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[33]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[34]  A. Takeshita,et al.  Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. , 1997, Journal of cardiovascular pharmacology.

[35]  A. Quyyumi,et al.  Nitric oxide activity in the atherosclerotic human coronary circulation. , 1997, Journal of the American College of Cardiology.

[36]  G. Kajiyama,et al.  Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients. , 1996, American heart journal.